Drawing for AFSTYLA CONNECT

USPTO serial 90768597

AFSTYLA CONNECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RENNEKER, CHRISTOPHER JOHN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AFSTYLA CONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON STREET, NWSUITE 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
009Electronic downloadable publications, namely, booklets, manuals, brochures, letters, informational flyers, teaching materials and forms for use by medical professionals, patients and caregivers in the field of medicine; downloadable software in the nature of a mobile application for healthcare messaging to patients and healthcare providersACTIVE—
016Printed publications, namely, booklets, manuals, brochures, letters, informational flyers, teaching materials and forms for use by medical professionals, patients and caregivers in the field of medicineACTIVE—
036Information on financial administration of patient reimbursement programs; Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications and medical treatment; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial co-pay assistance programs to patientsACTIVE—
044Medical services, namely, providing medical information concerning blood products, providing medical information concerning pharmaceutical products, including providing information on preparing and self-administering medications; health care, namely, providing health care information by telephone, the internet, and through the distribution of printed matter; charitable services, namely, providing medical information to patients and caregivers for obtaining medications and medical treatment; Providing medical information for patients diagnosed with medical conditions regarding available resources and treatments and steps and actions for wellness, physical fitness and healthy living; providing medical counseling, mentoring and guidance for patients with medical conditions; medical services, namely, providing medical information through charitable actions in the nature of information for the continuance of medication for those who are underinsured, uninsured, or who have experienced a lapse in insurance coverage; Providing medical treatment information by text in the field of blood conditions, vaccines, and general health to patients and health care providers; Providing medical treatment information by email in the field of blood conditions, vaccines, and general health to patients and health care providers; providing an Internet website portal featuring medical treatment information for patients and healthcare providers in the field of blood conditions, vaccines and general health; nursing servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 13, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 13, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2025EX5GSOU EXTENSION 5 GRANTED—
May 19, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2025EXT5SOU EXTENSION 5 FILED—
Aug 7, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 7, 2024EX4GSOU EXTENSION 4 GRANTED—
Aug 7, 2024EXT4SOU EXTENSION 4 FILED—
Aug 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 29, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 28, 2024EX3GSOU EXTENSION 3 GRANTED—
Feb 28, 2024EXT3SOU EXTENSION 3 FILED—
Feb 28, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 2, 2023EX2GSOU EXTENSION 2 GRANTED—
Aug 2, 2023EXT2SOU EXTENSION 2 FILED—
Aug 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 8, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 6, 2023EX1GSOU EXTENSION 1 GRANTED—
Feb 6, 2023EXT1SOU EXTENSION 1 FILED—
Feb 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 6, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 12, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 12, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 22, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 2, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 2, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2021DOCKASSIGNED TO EXAMINER—
Aug 31, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance